De-escalation of biological treatment in inflammatory bowel disease: A comprehensive review.

Francisco Javier García-AlonsoMaría Chaparro

Published in: Journal of Crohn's & colitis (2023)

Any consideration for de-escalation of biological therapy in IBD must be tailored, taking into account the risks and consequences of a flare and patients' preferences.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
randomized controlled trial
clinical trial
smoking cessation
bone marrow
human health
decision making